Meerab Majeed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Meerab Majeed has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mohannad Abu-Hilal
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada
2 shared publications - Adom Bondzi-Simpson
Department of Surgery, University of Toronto, Toronto, Ontario, Canada
1 shared publication Ahmad Al-Hajji
Division of Dermatology, McMaster University, Hamilton, ON, Canada
1 shared publicationAjibola Anifowose
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Ontario, Canada
1 shared publication- Aljeena Rahat Qureshi
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
1 shared publication - Amber Fozia Khan
School of Public Health Sciences, University of Waterloo, Waterloo, ON N2L 3G1, Canada
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Efficacy and Safety of Topical 1.5% Ruxolitinib for Chronic Hand Eczema in Real‑World Practice
Background: Chronic hand eczema (CHE) is defined as hand eczema persisting for >3 months or recurring at least twice within 12 months and is associated with significant pruritus, pain, functional impairment, and psychosocial burden. Conventional treatments are frequently inadequate or limited by adverse events (AEs). Topical Janus kinase inhibitors represent a novel therapeutic option. While delgocitinib has recently been approved for CHE, emerging evidence suggests topical ruxolitinib may also be effective. Objectives: To evaluate the real-world efficacy and safety of topical ruxolitinib 1.5% cream in patients with moderate-to-severe CHE. Methods: This retrospective real-world case series included 13 patients with CHE treated with ruxolitinib 1.5% cream applied twice daily for ~12 weeks. Baseline demographic and clinical characteristics were collected, including CHE subtype and disease severity. Treatment response was assessed using the Physician’s Global Assessment (PGA). Results: The cohort included 8 females and 5 males with a mean age of 33.8 years and mean disease duration of 6.9 years. Most patients had hyperkeratotic CHE (76.9%), with all exhibiting moderate-to-severe disease at baseline (PGA 3-4). By week 12, 92.3% of patients achieved a PGA score of 0 or 1, indicating clear or almost clear disease. No treatment-related AEs were reported during follow-up. Conclusions: Topical ruxolitinib demonstrated high rates of clinical improvement and favorable tolerability in this real-world CHE cohort. Despite limitations including small sample size and retrospective design, these findings support ruxolitinib as a promising option for recalcitrant CHE and warrant confirmation in larger randomized controlled trials.
- 22 June 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Open AccessEfficacy and Safety of Topical 1.5% Ruxolitinib for Chronic Hand Eczema in Real‑World Practice
Background: Chronic hand eczema (CHE) is defined as hand eczema persisting for >3 months or recurring at least twice within 12 months and is associated with significant pruritus, pain, functional impairment, and psychosocial burden. Conventional treatments are frequently inadequate or limited by adverse events (AEs). Topical Janus kinase inhibitors represent a novel therapeutic option. While delgocitinib has recently been approved for CHE, emerging evidence suggests topical ruxolitinib may also be effective. Objectives: To evaluate the real-world efficacy and safety of topical ruxolitinib 1.5% cream in patients with moderate-to-severe CHE. Methods: This retrospective real-world case series included 13 patients with CHE treated with ruxolitinib 1.5% cream applied twice daily for ~12 weeks. Baseline demographic and clinical characteristics were collected, including CHE subtype and disease severity. Treatment response was assessed using the Physician’s Global Assessment (PGA). Results: The cohort included 8 females and 5 males with a mean age of 33.8 years and mean disease duration of 6.9 years. Most patients had hyperkeratotic CHE (76.9%), with all exhibiting moderate-to-severe disease at baseline (PGA 3-4). By week 12, 92.3% of patients achieved a PGA score of 0 or 1, indicating clear or almost clear disease. No treatment-related AEs were reported during follow-up. Conclusions: Topical ruxolitinib demonstrated high rates of clinical improvement and favorable tolerability in this real-world CHE cohort. Despite limitations including small sample size and retrospective design, these findings support ruxolitinib as a promising option for recalcitrant CHE and warrant confirmation in larger randomized controlled trials.
- Open Access
- 26 February 2026
- Published by SAGE Publications in Plastic Surgery
Evaluation of Commitment to Equity, Diversity, and Inclusion on Canadian Plastic Surgery Residency Program Websites
Introduction: Equity, diversity, and inclusion (EDI) are increasingly recognized as essential to medical education. Although Canadian medical schools have advanced EDI efforts, gaps persist in postgraduate training, including plastic surgery. In the context of virtual recruitment, residency websites function as key reflections of program values. This study assesses the visibility of EDI-related content on Canadian plastic surgery residency program websites. Methods: We conducted a cross-sectional content analysis of all 14 plastic surgery programs participating in the 2026 CaRMS match. Program websites, CaRMS profiles, and CANPREPP pages were reviewed (August-September 2025). EDI content was assessed using 8 binary criteria adapted from Cummings et al. Two reviewers independently evaluated each site. Descriptive statistics summarized EDI scores overall and by region, language, and local visible minority population. Results: The mean number of EDI criteria met was 0.43 (SD = 0.76), ranging from 0 to 5. Only 1 program met more than 1 criterion. Twelve programs fulfilled zero criteria. The most common elements included standalone EDI statements (n = 2), followed by isolated mentions in mission statements, dedicated pages, or appointed leadership (n = 1 each). No programs displayed underrepresented minority-specific supports, EDI-related video content, or transgender-inclusive messaging. Stratified findings showed slightly higher scores in Anglophone programs (0.55) and cities with >30% visible minority populations (1.00), though overall representation remained limited. Conclusion: Canadian plastic surgery residency program websites show sparse and inconsistent EDI representation. Strengthening online EDI communication is critical to promoting equitable recruitment and diversity in surgical education.
- 26 February 2026
- Published by SAGE Publications in Plastic Surgery
Open AccessEvaluation of Commitment to Equity, Diversity, and Inclusion on Canadian Plastic Surgery Residency Program Websites
Introduction: Equity, diversity, and inclusion (EDI) are increasingly recognized as essential to medical education. Although Canadian medical schools have advanced EDI efforts, gaps persist in postgraduate training, including plastic surgery. In the context of virtual recruitment, residency websites function as key reflections of program values. This study assesses the visibility of EDI-related content on Canadian plastic surgery residency program websites. Methods: We conducted a cross-sectional content analysis of all 14 plastic surgery programs participating in the 2026 CaRMS match. Program websites, CaRMS profiles, and CANPREPP pages were reviewed (August-September 2025). EDI content was assessed using 8 binary criteria adapted from Cummings et al. Two reviewers independently evaluated each site. Descriptive statistics summarized EDI scores overall and by region, language, and local visible minority population. Results: The mean number of EDI criteria met was 0.43 (SD = 0.76), ranging from 0 to 5. Only 1 program met more than 1 criterion. Twelve programs fulfilled zero criteria. The most common elements included standalone EDI statements (n = 2), followed by isolated mentions in mission statements, dedicated pages, or appointed leadership (n = 1 each). No programs displayed underrepresented minority-specific supports, EDI-related video content, or transgender-inclusive messaging. Stratified findings showed slightly higher scores in Anglophone programs (0.55) and cities with >30% visible minority populations (1.00), though overall representation remained limited. Conclusion: Canadian plastic surgery residency program websites show sparse and inconsistent EDI representation. Strengthening online EDI communication is critical to promoting equitable recruitment and diversity in surgical education.
- Open Access
Bridging the representation gap in the surgical workforce: a scoping review protocol of programmes and interventions to support surgical careers for underrepresented minority learners
Introduction Despite increasing proportions of underrepresented minority (URM) medical school graduates, their progression into surgical training and leadership remains disproportionately low. Barriers such as financial constraints, limited mentorship and implicit bias contribute to this disparity, creating a disconnect between the diversity of patient populations and those providing care. While interventions such as mentorship programmes and pipeline initiatives have been implemented, their overall effectiveness has not been systematically evaluated. The primary aim of this scoping review is to map the current landscape of interventions, programmes and policies designed to enhance access to surgical careers for URM learners. Methods and analysis Searches will be conducted on EMBASE, Web of Science and OVID MEDLINE. Three independent reviewers will screen references, extract data and perform analyses with disagreements adjudicated by a fourth reviewer. This review will include studies conducted across all levels of training: secondary (high school or secondary school), postsecondary (undergraduate, medical school) and postgraduate (residency, fellowship), with no geographical restrictions. The definition of URM will be accepted as reported within each individual study, allowing for variability in racial, ethnic, gender, socioeconomic or other criteria. The review will include any structured interventions, programmes or policies aimed at increasing URM representation in surgical education. Data on the nature, duration and target population of each intervention will be extracted. The primary outcome will be the reported impact of interventions on URM representation or participation in surgical education. Secondary outcomes will include characteristics of the study participants, definitions of URM status and any qualitative or quantitative evaluations of intervention effectiveness. Ethics and dissemination Research ethics approval is not required under University of Toronto policy. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results will be disseminated to relevant stakeholders at conference presentation(s) and submitted for publication in a peer-reviewed journal.
Open AccessBridging the representation gap in the surgical workforce: a scoping review protocol of programmes and interventions to support surgical careers for underrepresented minority learners
Introduction Despite increasing proportions of underrepresented minority (URM) medical school graduates, their progression into surgical training and leadership remains disproportionately low. Barriers such as financial constraints, limited mentorship and implicit bias contribute to this disparity, creating a disconnect between the diversity of patient populations and those providing care. While interventions such as mentorship programmes and pipeline initiatives have been implemented, their overall effectiveness has not been systematically evaluated. The primary aim of this scoping review is to map the current landscape of interventions, programmes and policies designed to enhance access to surgical careers for URM learners. Methods and analysis Searches will be conducted on EMBASE, Web of Science and OVID MEDLINE. Three independent reviewers will screen references, extract data and perform analyses with disagreements adjudicated by a fourth reviewer. This review will include studies conducted across all levels of training: secondary (high school or secondary school), postsecondary (undergraduate, medical school) and postgraduate (residency, fellowship), with no geographical restrictions. The definition of URM will be accepted as reported within each individual study, allowing for variability in racial, ethnic, gender, socioeconomic or other criteria. The review will include any structured interventions, programmes or policies aimed at increasing URM representation in surgical education. Data on the nature, duration and target population of each intervention will be extracted. The primary outcome will be the reported impact of interventions on URM representation or participation in surgical education. Secondary outcomes will include characteristics of the study participants, definitions of URM status and any qualitative or quantitative evaluations of intervention effectiveness. Ethics and dissemination Research ethics approval is not required under University of Toronto policy. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results will be disseminated to relevant stakeholders at conference presentation(s) and submitted for publication in a peer-reviewed journal.
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Surgical outcomes in patients treated with deroofing for hidradenitis suppurativa
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Surgical outcomes in patients treated with deroofing for hidradenitis suppurativa
- Top Cited PapersOpen Access
- 4 September 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9342
What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review
Background: During the COVID-19 crisis, an apparent growth in vaccine hesitancy has been noticed due to different factors and reasons. Therefore, this scoping review was performed to determine the prevalence of intention to use COVID-19 vaccines among adults aged 18–60, and to identify the demographic, social, and contextual factors that influence the intention to use COVID-19 vaccines. Methods: This scoping review was conducted by using the methodological framework for scoping review outlined by Arksey and O’Malley. A search strategy was carried out on four electronic databases: PubMed, Scopus, CINAHL, and PsycINFO. All peer-reviewed articles published between November 2019 and December 2020 were reviewed. Data were extracted to identify the prevalence of, and factors that influence, the intention to use COVID-19 vaccines. Results: A total of 48 relevant articles were identified for inclusion in the review. Outcomes presented fell into seven themes: demographics, social factors, vaccination beliefs and attitudes, vaccine-related perceptions, health-related perceptions, perceived barriers, and vaccine recommendations. Age, gender, education level, race/ethnicity, vaccine safety and effectiveness, influenza vaccination history, and self-protection from COVID-19 were the most prominent factors associated with intention to use COVID-19 vaccines. Furthermore, the majority of studies (n = 34/48) reported a relatively high prevalence of intention to get vaccinated against COVID-19, with a range from 60% to 93%. Conclusion: This scoping review enables the creation of demographic, social, and contextual constructs associated with intention to vaccinate among the adult population. These factors are likely to play a major role in any targeted vaccination programs, particularly COVID-19 vaccination. Thus, our review suggests focusing on the development of strategies to promote the intention to get vaccinated against COVID-19 and to overcome vaccine hesitancy and refusal. These strategies could include transparent communication, social media engagement, and the initiation of education programs.
- 4 September 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9342
Top Cited PapersOpen AccessWhat Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review
Background: During the COVID-19 crisis, an apparent growth in vaccine hesitancy has been noticed due to different factors and reasons. Therefore, this scoping review was performed to determine the prevalence of intention to use COVID-19 vaccines among adults aged 18–60, and to identify the demographic, social, and contextual factors that influence the intention to use COVID-19 vaccines. Methods: This scoping review was conducted by using the methodological framework for scoping review outlined by Arksey and O’Malley. A search strategy was carried out on four electronic databases: PubMed, Scopus, CINAHL, and PsycINFO. All peer-reviewed articles published between November 2019 and December 2020 were reviewed. Data were extracted to identify the prevalence of, and factors that influence, the intention to use COVID-19 vaccines. Results: A total of 48 relevant articles were identified for inclusion in the review. Outcomes presented fell into seven themes: demographics, social factors, vaccination beliefs and attitudes, vaccine-related perceptions, health-related perceptions, perceived barriers, and vaccine recommendations. Age, gender, education level, race/ethnicity, vaccine safety and effectiveness, influenza vaccination history, and self-protection from COVID-19 were the most prominent factors associated with intention to use COVID-19 vaccines. Furthermore, the majority of studies (n = 34/48) reported a relatively high prevalence of intention to get vaccinated against COVID-19, with a range from 60% to 93%. Conclusion: This scoping review enables the creation of demographic, social, and contextual constructs associated with intention to vaccinate among the adult population. These factors are likely to play a major role in any targeted vaccination programs, particularly COVID-19 vaccination. Thus, our review suggests focusing on the development of strategies to promote the intention to get vaccinated against COVID-19 and to overcome vaccine hesitancy and refusal. These strategies could include transparent communication, social media engagement, and the initiation of education programs.